RAKESH SHAH: Open Payments
NPI 1942419692 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 68 payments from 16 companies in 2025. Trend: 2023 $1,195 · 2024 $1,692 · 2025 $1,397
Food & beverage: $1,397
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $260 |
| Janssen Pharmaceuticals, Inc | 5 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Collegium Pharmaceutical, Inc. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| ABBVIE INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $56 |
Products named: COBENFY, TRINTELLIX, FANAPT, ABILIFY ASIMTUFII, SPRAVATO, Jornay PM, CAPLYTA, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
